Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Program    source : Investors.biomarin.com    save search
BioMarin to Present ROCTAVIAN™ (valoctocogene roxaparvovec) Data from Longest and Largest Hemophilia Gene Therapy Clinical Trial Program at the International Society on Thrombosis and Haemostasis (ISTH) 2023 Congress
Published: 2023-06-22 (Crawled : 12:00) - investors.biomarin.com
BMRN | $91.2 -0.93% -0.89% 550 twitter stocktwits trandingview |
Health Technology
 | | O: -0.32% H: 0.18% C: -0.44%
international program trial therapy
BioMarin Provides Updates on Progress in Gene Therapy Programs
Published: 2022-02-17 (Crawled : 22:00) - investors.biomarin.com
BMRN | $91.2 -0.93% -0.89% 550 twitter stocktwits trandingview |
Health Technology
 | | O: -1.89% H: 1.47% C: -4.21%
gene therapy program therapy
Gainers vs Losers
61% 39%

Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M twitter stocktwits trandingview |

BHIL | $0.1793 -4.37% 19.24% 340K twitter stocktwits trandingview |
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K twitter stocktwits trandingview |

CI | $352.28 -0.11% 13.53% 2 twitter stocktwits trandingview |
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K twitter stocktwits trandingview |
n/a
BMTX 4 | $1.545 0.98% 10.03% 2.5K twitter stocktwits trandingview |
Information
TAL | $12.26 0.57% 9.22% 12M twitter stocktwits trandingview |
Consumer Services
MTH | $154.69 -2.21% 7.56% 64 twitter stocktwits trandingview |
Consumer Durables
ASXC | $0.243 -2.41% 7.0% 1.1M twitter stocktwits trandingview |
Manufacturing
IHT P | $1.3712 0.82% 6.48% 0 twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.